Confirma breast MRI CAD provider for RadNet Management

TriMed Staff | | Health Imaging | Breast MRI
Confirma Inc. will provide its CADstream system to RadNet Management Inc., a California provider of medical imaging services, making it the exclusive breast MRI (magnetic resonance imaging) CAD (computer aided detection) system for RadNet's 55 diagnostic imaging centers.

RadNet previously bought two CADstream systems and the agreement includes an additional sale and installation of two more CADstream systems with the option to buy additional systems as the number of RadNet sites increases.

CADstream's automated features include image registration, subtractions, angiogenesis maps, interactive real-time contrast curves, multiplanar reformatting, maximum intensity projections (MIPs), volume summaries and the SureLoc interventional guidance tool.

TriMed Staff

Related Content

New low-field scanner detects cancer spread better than traditional breast MRI
MRI technique makes breast cancer 'glow' on imaging
Deep learning reconstruction cuts breast MRI scan times in half
AI effectively flags mammograms of women who would benefit from supplemental MRI
AI model spots up to 30% of breast cancers missed on MRI
Breast cancer only visible via MRI is often less aggressive

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.